Hudson Bay Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.67M	Sell	490,369 -527,005	-52%	-$4.09M	0.03%	531
2025 Q4	$7.94M	Buy	+1,017,374	New	+$7.35M	0.05%	386
2025 Q3	–	Sell	-304,772	Closed	-$2.73M	–	1268
2025 Q2	$2.73M	Sell	304,772 -193,907	-39%	-$1.81M	0.02%	709
2025 Q1	$3.74M	Buy	+498,679	New	+$4.02M	0.02%	678
2024 Q3	–	Sell	-180,000	Closed	-$1.11M	–	872
2024 Q2	$1.11M	Sell	180,000 -120,000	-40%	-$662K	0.01%	596
2024 Q1	$1.52M	Buy	300,000 +170,000	+131%	+$956K	0.01%	500
2023 Q4	$779K	Buy	130,000 +65,000	+100%	+$377K	0.01%	538
2023 Q3	$460K	Buy	65,000 +300	+0.5%	+$2.15K	﹤0.01%	604
2023 Q2	$455K	Buy	64,700 +22,200	+52%	+$178K	﹤0.01%	633
2023 Q1	$354K	Buy	42,500 +17,500	+70%	+$168K	﹤0.01%	636
2022 Q4	$287K	Buy	+25,000	New	+$312K	﹤0.01%	738
2019 Q2	–	Sell	-140,000	Closed	-$1.14M	–	447
2019 Q1	$1.14M	Buy	140,000 +10,000	+8%	+$85.6K	0.03%	540
2018 Q4	$1.05M	Sell	130,000 -90,000	-41%	-$700K	0.03%	629
2018 Q3	$1.68M	Sell	220,000 -80,000	-27%	-$537K	0.04%	497
2018 Q2	$1.72M	Sell	300,000 -260,000	-46%	-$1.43M	0.05%	545
2018 Q1	$2.67M	Buy	+560,000	New	+$2.88M	0.1%	384